Edesa Biotech

EDSA · NASDAQ

$2.77+$0.01 (+0.36%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $2.76

Latest news

NewsOct 20, 5:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseOct 15, 9:15 AM ETGlobe Newswire
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
NewsAug 26, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 24, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsAug 20, 8:06 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsAug 20, 6:20 AM ETAkanksha Bakshi
Edesa Biotech Stock Sinks After Fresh Capital Raise
Press releaseAug 19, 10:20 PM ETGlobe Newswire
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
NewsAug 19, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseAug 19, 4:01 PM ETGlobe Newswire
Edesa Biotech Announces Proposed Public Offering
Press releaseAug 13, 4:15 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
Press releaseJun 11, 9:15 AM ETGlobe Newswire
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
Press releaseJun 5, 9:20 AM ETGlobe Newswire
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
NewsMay 19, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseMay 19, 9:15 AM ETGlobe Newswire
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
NewsMay 18, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseMay 14, 4:30 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
NewsMay 8, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsApr 22, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseMar 31, 4:20 PM ETGlobe Newswire
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
Press releaseMar 26, 9:15 AM ETGlobe Newswire
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
NewsMar 6, 12:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMar 3, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsFeb 27, 12:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsFeb 25, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsFeb 24, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseFeb 24, 9:15 AM ETGlobe Newswire
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
Press releaseFeb 13, 4:20 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
Press releaseDec 12, 4:20 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal Year 2025 Results
Press releaseOct 31, 4:30 PM ETGlobe Newswire
Edesa Biotech Announces Upcoming Conference Schedule
NewsOct 28, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseOct 28, 7:45 AM ETGlobe Newswire
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
Press releaseAug 8, 4:35 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
Press releaseMay 14, 4:15 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
Press releaseApr 28, 4:30 PM ETGlobe Newswire
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Press releaseApr 4, 4:15 PM ETGlobe Newswire
Edesa Biotech Announces Chief Financial Officer Transition
Press releaseFeb 14, 4:15 PM ETGlobe Newswire
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
NewsFeb 13, 2:00 PM ETAvi Kapoor
Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings
NewsFeb 13, 12:36 PM ETAvi Kapoor
Nasdaq Surges 150 Points; Cisco Earnings Top Views

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Tuesday's After-Market Session

Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Edesa Biotech Stock Sinks After Fresh Capital Raise

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

12 Health Care Stocks Moving In Wednesday's After-Market Session

Edesa Biotech Announces Proposed Public Offering

Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

12 Health Care Stocks Moving In Tuesday's Intraday Session

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

12 Health Care Stocks Moving In Monday's Intraday Session

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Edesa Biotech Reports Fiscal Year 2025 Results

Edesa Biotech Announces Upcoming Conference Schedule

12 Health Care Stocks Moving In Tuesday's Intraday Session

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Edesa Biotech Announces Chief Financial Officer Transition

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings

Nasdaq Surges 150 Points; Cisco Earnings Top Views